Abstract:Institutions: STONY BROOK MEDICAL CENTERRATIONALE: Lung Cancer screening for the high-risk smoking population has been proven to save lives. However, in 2022, 20% of newly diagnosed lung cancers (47,300) were in nonsmokers. These patients were found to be diagnosed at later stages. This may be at least partly due to not meeting criteria for and participating in current lung cancer screening. This study aims to describe characteristics of a never smoker patient population to help identify common risk factors which might merit inclusion in lung cancer screening and thus improve patient outcomes. Methods: This retrospective single center study included never-smoker patients diagnosed with lung nodules and never-smoker patients diagnosed with lung cancer from 2016 to 2022. Data was obtained from the Stony Brook Medical Center electronic medical record. 16,056 patients were identified as never-smokers who were asked by the medical assistant if they ever smoked in their lifetime. Patients were eliminated if they had any smoking history up to first diagnosis date. Demographics, radiology, histology, diagnosis dates, comorbidities, smoking status, and exposures collected through ICD10 codes and not self-reported, were investigated. Results: Of 16,056 never-smoking patients, 9315 (58.02%) were females diagnosed with lung nodules and 6741 (41.98%) were males diagnosed with lung nodules. The univariate analysis showed significant differences between gender, age at nodule diagnosis, and patients with and without comorbidities including chronic obstructive pulmonary disease (COPD), hypertension (HTN), and family history (FHX) of lung cancer. The percentage of lung cancer patients among females was significantly higher than among males. Patients having lung cancer were older. The percentages of lung cancer patients with these comorbidities were significantly higher than those without. However, there was no significant difference found between patients with and without diabetes mellitus (DM). The multivariable logistic regression suggested that age at nodule diagnosis and comorbidities including COPD (which included asthma, emphysema and chronic bronchitis) and family history of lung cancer were significantly associated with lung cancer. Older patients and patients with those comorbidities had a higher risk of developing cancer than those who were younger or without those comorbidities. The study excluded HTN and included age at nodule diagnosis in the logistic regression model as HTN was found to be protective against lung cancer due to age at lung nodule diagnosis. Please refer to the appendix for further details. Conclusion: Never-smoker patients who were older and with COPD and Family History of lung cancer had higher risk of developing lung cancer than younger patients without these comorbidities. In this study, gender had no impact on outcome.

A family history of cancer and lung cancer risk in never-smokers: A clinic-based case–control study

Increased risk of cancer among relatives of patients with lung cancer in China

Family History of Cancer and Risk of Lung Cancer among Nonsmoking Chinese Women

Lung Cancer Risk in Non-Smoking Females with a Familial History of Cancer: a Multi-Center Prospective Cohort Study in China

Family History of Cancer and Head and Neck Cancer Risk in a Chinese Population.

Combined effects of lung disease history, environmental exposures, and family history of lung cancer to susceptibility of lung cancer in Chinese non-smokers

Clinical and Genetic Features of Lung Squamous Cell Cancer in Never-Smokers.

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.

Lung cancer in nonsmokers- A risk factor analysis

A Case–control Study of Lung Cancer and Environmental Tobacco Smoke among Nonsmoking Women Living in Shanghai, China

Diet and the Risk of Head-and-neck Cancer among Never-Smokers and Smokers in a Chinese Population.

Title : P 53 genetic polymorphisms , interactions with lifestyle factors and lung cancer risk : a case control study in a Chinese population

A Prospective Study of Immune and Inflammation Markers and Risk of Lung Cancer among Female Never Smokers in Shanghai.

Reproductive factors and risk of lung cancer among 300,000 Chinese female never-smokers: evidence from the China Kadoorie Biobank study

Genome-wide Association Analysis Identifies New Lung Cancer Susceptibility Loci in Never-Smoking Women in Asia

Family History of Malignancies and Risk of Breast Cancer: Prospective Data from the Shanghai Women’s Health Study

Abstract LB-186: Genetic Variants and Risk of Lung Cancer in Never-Smokers: A Genome-Wide Association Study

Bladder cancer risk as modified by family history and smoking.

Family Cancer History Affecting Risk of Colorectal Cancer in a Prospective Cohort of Chinese Women

Cancer Diagnosis in First-Degree Relatives and Non-Small Cell Lung Cancer Risk: Results from a Multi-Centre Case–control Study in Europe

Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies